InvestorsHub Logo

123414

10/07/19 7:47 AM

#3655 RE: 123414 #3654

The Company anticipates that patient enrollment and treatment will escalate rapidly with the increased momentum as it launches additional clinical study sites, as UHN has now treated its second patient.



https://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=7166363967422512&topic=TLTFF&symbology=null&cp=null&webmasterId=90338